← back to search

Françoise Berger

Institut d'Économie Industrielle · FR
Area of research
Pathology and Forensic Medicine · Genetics
Research interest
Research interests include Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, Viral-associated cancers and disorders, and Cutaneous lymphoproliferative disorders research.
h-index
55
citations
12,393
works
226
NIH funding
primary concept
email

Recent publications

Are random biopsies still useful for the detection of neoplasia in patients with IBD undergoing surveillance colonoscopy with chromoendoscopy?
Gut 2017cited by 165position: middledoi
Exome sequencing identifies recurrent <i>BCOR</i> alterations and the absence of <i>KLF2</i> , <i>TNFAIP3</i> and <i>MYD88</i> mutations in splenic diffuse red pulp small B-cell lymphoma
Haematologica 2017cited by 74position: middledoi
Primary cardiac lymphoma: diagnosis, treatment and outcome in a modern series
Hematological Oncology 2016cited by 69position: middledoi
Splenic diffuse red pulp lymphoma has a distinct pattern of somatic mutations amongst B-cell malignancies
Leukemia & lymphoma/Leukemia and lymphoma 2016cited by 32position: middledoi
High-dose cytarabine does not overcome the adverse prognostic value of CDKN2A and TP53 deletions in mantle cell lymphoma
Blood 2015cited by 157position: middledoi
Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma
Blood 2014cited by 536position: middledoi
Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome
Blood 2013cited by 249position: middledoi
Long-term follow-up analysis of 100 patients with splenic marginal zone lymphoma treated with splenectomy as first-line treatment
Leukemia & lymphoma/Leukemia and lymphoma 2013cited by 88position: middledoi
Peripheral blood involvement in patients with follicular lymphoma: a rare disease manifestation associated with poor prognosis
British Journal of Haematology 2013cited by 41position: middledoi
Early stage follicular lymphoma: what is the clinical impact of the first-line treatment strategy?
Journal of Hematology & Oncology 2013cited by 37position: middledoi
Nodal marginal zone B-cell lymphoma: a diagnostic and therapeutic dilemma.
PubMed 2012cited by 28position: middle

Grants

No grants ingested yet.

Frequent collaborators

Gilles Salles · Universidade Federal do Estado do Rio de Janeiro8 papers (2012–2017)Bertrand Coiffier · Hospices Civils de Lyon5 papers (2012–2016)Alexandra Traverse‐Glehen · Université Claude Bernard Lyon 15 papers (2012–2017)Evelyne Callet-Bauchu · Centre de Recherche en Cancérologie de Lyon4 papers (2013–2017)Pascale Felman · Université Claude Bernard Lyon 14 papers (2013–2017) · 3 papers (2013–2016)Catherine Thiéblemont · Inserm3 papers (2012–2015)Lucile Baseggio · Université Claude Bernard Lyon 13 papers (2013–2017)Pierre Feugier · Délégation Centre-Est2 papers (2013–2015)Sandrine Hayette · Université Claude Bernard Lyon 12 papers (2016–2017)Kaddour Chabane · Université Claude Bernard Lyon 12 papers (2016–2017)Laurent Jallades · Centre de Recherche en Cancérologie de Lyon2 papers (2016–2017)Laure Lebras · Université Claude Bernard Lyon 12 papers (2013–2013)Josette Brière · Délégation Paris 72 papers (2013–2015)Aurélie Verney · Université Claude Bernard Lyon 12 papers (2016–2017)Wolfgang Hiddemann · Deutsche Forschungsgemeinschaft1 papers (2015–2015)Jean‐Pierre Magaud · Université Claude Bernard Lyon 11 papers (2017–2017) · 1 papers (2013–2013)Jean-François Cordier · University of St.Gallen1 papers (2016–2016)Michael Unterhalt · Technical University of Munich1 papers (2015–2015)